MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, JANX has $1,028,225K in assets. $86,690K in debts. $51,828K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1700.84%
Quick Ratio
1700.84%
Cash Ratio
87.97%
Debt to Asset Ratio
8.43%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Current portion of deferred reve...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
51,828 52,334 48,389 52,446
Accounts receivable, net
35,000 ---
Short-term investments
904,558 914,233 940,604 943,565
Prepaid expenses and other current assets
10,663 9,320 9,093 9,542
Total current assets
1,002,049 975,887 998,086 1,005,553
Restricted cash
816 816 816 816
Total property and equipment
10,898 10,819 10,813 -
Less accumulated depreciation
7,352 6,967 6,499 -
Property and equipment, net
3,546 3,852 4,314 4,688
Operating lease right-of-use assets
17,870 18,402 18,923 18,462
Other long-term assets
3,944 2,608 2,627 2,693
Total assets
1,028,225 1,001,565 1,024,766 1,032,212
Accounts payable
3,376 4,971 3,395 3,477
Accrued expenses
15,476 17,633 22,156 16,029
Current portion of deferred revenue
37,591 ---
Current portion of operating lease liabilities
2,472 2,393 2,280 1,873
Total current liabilities
58,915 24,997 27,831 21,379
Deferred revenue, net of current portion
8,676 ---
Operating lease liabilities, net of current portion
19,099 19,746 20,380 20,317
Total liabilities
86,690 44,743 48,211 41,696
Common stock, 0.001 par value authorized shares - 200,000,000 at march 31, 2026 and december 31, 2025 issued and outstanding shares - 60,865,458 and 60,384,283 at march 31, 2026 and december 31, 2025, respectively
60 60 60 59
Additional paid-in capital
1,316,642 1,303,828 1,291,369 1,281,833
Accumulated other comprehensive income
576 4,316 4,562 3,747
Accumulated deficit
-375,743 -351,382 -319,436 -295,123
Total stockholders' equity
941,535 956,822 976,555 990,516
Total liabilities and stockholders' equity
1,028,225 1,001,565 1,024,766 1,032,212
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$904,558K Cash and cashequivalents$51,828K Accounts receivable, net$35,000K Prepaid expenses andother current assets$10,663K Total property andequipment$10,898K Total current assets$1,002,049K Operating leaseright-of-use assets$17,870K Other long-termassets$3,944K Property and equipment,net$3,546K Restricted cash$816K Less accumulateddepreciation$7,352K Total assets$1,028,225K Total liabilities andstockholders' equity$1,028,225K Total stockholders'equity$941,535K Total liabilities$86,690K Accumulated deficit-$375,743K Additional paid-in capital$1,316,642K Total currentliabilities$58,915K Operating leaseliabilities, net of current...$19,099K Deferred revenue, net ofcurrent portion$8,676K Accumulated othercomprehensive income$576K Common stock, 0.001 parvalue authorized...$60K Current portion ofdeferred revenue$37,591K Accrued expenses$15,476K Accounts payable$3,376K Current portion ofoperating lease...$2,472K

Janux Therapeutics, Inc. (JANX)

Janux Therapeutics, Inc. (JANX)